Market Movers
Pre-Market and After Hours Market Movers
-
Stock Market Today: Stocks Slide as Tech Sell-Off Deepens and Layoff Worries Spread
U.S. stocks dove on Thursday as continued pressure on Big Tech and troubling labor data reignited fears about stretched valuations…
Read More » -
Cadre Holdings’ $175M Deal With TYR Tactical: Can This Transform Its Global Defense Play?
Cadre to acquire TYR Tactical for $175M in cash and stock, expanding into defense gear. The deal adds $92.6M revenue,…
Read More » -
Community Health Systems In Play: Why Tenor Health Foundation Could Be Circling This Small-Cap Hospital Operator!
CYH advances divestiture strategy, selling 3 PA hospitals to Tenor Health Foundation. Deal aligns with leverage reduction and turnaround plan,…
Read More » -
Bitcoin Drops to $101,000 Amid Government Shutdown
Bitcoin extended losses on Tuesday, tumbling more than 5% to trade near $101,000 as rising selling pressure and stalled liquidity…
Read More » -
Stock Market Today: Nasdaq, S&P 500 Slide as Valuation Fears Hit Big Tech
U.S. stocks fell on Tuesday as concerns over lofty valuations hit investor confidence despite a steady stream of solid earnings.
Read More » -
Big Tech’s AI Spending Soars: What It Means for the Market
Big tech companies are ramping up their AI investments at a rapid pace, and the scale of the outlays suggests…
Read More » -
Stock Market Today: Dow Slips While Nasdaq Pops as Amazon-OpenAI Deal Fuels AI Rally
The U.S. stock market kicked off the week mixed as tech stocks kept the momentum going while the broader market…
Read More » -
Meta’s AI Spending Shocks Wall Street as Big Tech Earnings Loom
Meta’s (META) latest earnings report sent shockwaves through Wall Street on Thursday, with shares falling more than 10% as investors…
Read More » -
Stock Market Today: Dow Climbs While Tech Stocks Slide Ahead of Apple and Amazon Results
U.S. stocks were mixed on Thursday as Wall Street digested a volatile earnings week and reacted to fresh signals from…
Read More » -
Avadel’s $2.1 Billion Deal With Alkermes Could Shake Up Sleep Medicine—Here’s How!
Avadel Pharmaceuticals’ $2.1B acquisition by Alkermes underscores Lumryz’s strong growth and profitability, with added upside tied to FDA approval for…
Read More »
